REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,263,512 | -31.7% | 22,200 | -39.1% | 0.05% | -26.5% |
| Q1 2023 | $3,314,398 | +135.8% | 36,454 | -1.5% | 0.07% | +106.1% |
| Q4 2022 | $1,405,630 | +201.0% | 37,000 | +98.9% | 0.03% | +175.0% |
| Q3 2022 | $467,000 | -25.0% | 18,600 | -9.3% | 0.01% | -25.0% |
| Q2 2022 | $623,000 | -78.2% | 20,500 | -76.5% | 0.02% | -76.1% |
| Q1 2022 | $2,856,000 | +239.6% | 87,164 | +173.2% | 0.07% | +235.0% |
| Q4 2021 | $841,000 | -85.7% | 31,900 | -45.5% | 0.02% | -87.7% |
| Q3 2021 | $5,886,000 | +110.1% | 58,500 | +195.5% | 0.16% | +80.0% |
| Q2 2021 | $2,802,000 | +746.5% | 19,800 | +638.8% | 0.09% | +650.0% |
| Q4 2020 | $331,000 | – | 2,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |